An update from our Chairman & CEO Daniel O’Day about our investigational treatment.
Together, we’re creating what’s possible.
From science to community outreach, we’re committed to making a healthier world.
Gilead launches the COMPASS Initiative™ to help address the HIV/AIDS epidemic in the Southern United States.
Supporting Elimination Efforts.
With the emergence of new therapies that have transformed chronic HCV treatment, it is now possible to eliminate the disease in certain populations.
We strive to help improve the lives of people with life-threatening illnesses around the world by giving them access to the medicine they need.